Demirdöğen, E. Et Al. 2022. SERUM CANCER FROM LUNG-6: PROMISING BIOMARKER TO DIFFERENTIATE CPFE FROM IPF. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.39, no.4 .

Demirdöğen, E., Görek Dilektaşlı, A., Acet Öztürk, N. A., Yeşilbursa, D., Budak, F., Coşkun, F., ... Öztürk, A.(2022). SERUM CANCER FROM LUNG-6: PROMISING BIOMARKER TO DIFFERENTIATE CPFE FROM IPF. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.39, no.4.

Demirdöğen, Ezgi Et Al. "SERUM CANCER FROM LUNG-6: PROMISING BIOMARKER TO DIFFERENTIATE CPFE FROM IPF," SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.39, no.4, 2022

Demirdöğen, Ezgi Et Al. "SERUM CANCER FROM LUNG-6: PROMISING BIOMARKER TO DIFFERENTIATE CPFE FROM IPF." SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.39, no.4, 2022

Demirdöğen, E. Et Al. (2022) . "SERUM CANCER FROM LUNG-6: PROMISING BIOMARKER TO DIFFERENTIATE CPFE FROM IPF." SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.39, no.4.

@article{article, author={Ezgi Demirdöğen Et Al. }, title={SERUM CANCER FROM LUNG-6: PROMISING BIOMARKER TO DIFFERENTIATE CPFE FROM IPF}, journal={SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES}, year=2022}